After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Recently, Yahoo Finance discussed the stock, revealing that PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
PTC Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $31.30 and fluctuated between $31.58 as its day high and $30.25 as its day low. The current market capitalization of PTC Therapeutics Inc is $2.40B. A total of 0.78 million shares were traded on the day, compared to an average of 1.11M shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, PTCT has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 23 BUYs and 42 SELLs from insiders. Insiders purchased 224,728 shares during that period but sold 198,281.
In the most recent transaction, Boulding Mark Elliott sold 794 shares of PTCT for 27.25 per share on Jan 30. After the transaction, the EXEC. VP AND CLO now owns 71,189 company shares. In a previous transaction on Jan 30, Almstead Neil Gregory sold 618 shares at 27.25 per share. PTCT shares that CHIEF TECHNICAL OPS OFFICER owns now total 61,202.
Among the insiders who sold shares, Pauwels Eric disposed of 366 shares on Jan 30 at a per-share price of $27.25. This resulted in the CHIEF BUSINESS OFFICER holding 44,181 shares of PTCT after the transaction. In another insider transaction, Utter Christine Marie sold 318 shares at $27.25 per share on Jan 30. Company shares held by the SVP, CHIEF ACCOUNTING OFFICER now total 35,528.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, PTCT has a high of $59.84 and a low of $17.53.
As of this writing, PTCT has an earnings estimate of -$1.25 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of -$0.56 per share and a lower estimate of -$1.93. The company reported an EPS of -$1.76 in the last quarter, which was -50.40% lower than expectations of -$1.17.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. PTCT’s latest balance sheet shows that the firm has $773.38M in Cash & Short Term Investments as of fiscal 2021. There were $535.38M in debt and $509.35M in liabilities at the time. Its Book Value Per Share was -$10.81, while its Total Shareholder’s Equity was $1.44M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PTCT is Buy with a score of 3.14.
